BioNTech’s Bold Strategy: Transformative Cancer Therapies Amidst Financial Turbulence
BioNTech, based in Mainz, is transitioning from a COVID-19 focus to pioneering cancer therapies, despite financial challenges. Fourth-quarter 2024 profits dropped, but results beat market expectations, highlighting resilience. The company…